An Exploratory Study: Can Native T1 Mapping Differentiate Sarcoma from Benign Soft Tissue Tumors at 1.5 T and 3 T?
Laura Dupont, Bénédicte M A Delattre, Marta Sans Merce, Pierre Alexandre Poletti, Sana Boudabbous, Dania Cioni, Brigitta G Baumert · 2024
Read An Exploratory Study: Can Native T1 Mapping Differentiate Sarcoma from Benign Soft Tissue Tumors at 1.5 T and 3 T? by Laura Dupont, Bénédicte M A Delattre, Marta Sans Merce, Pierre Alexandre Poletti, Sana Boudabbous, Dania Cioni, Brigitta G Baumert (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11592662.txt.
Description
Laura Dupont, Bénédicte Delattre, Marta Sans Merce, Pierre Alexandre Poletti, and Sana Boudabbous test whether an MRI measure can separate malignant soft-tissue tumors from harmless ones without contrast dye. Their 2024 exploratory study uses native T1 mapping, a scan that times how tissue magnetization recovers. That timing had already proved useful for reading tumors in other organs.
From 316 cases, sixteen sarcomas and nine benign tumors qualified, all untreated and scanned at both field strengths. T1 values in the tumors did not differ significantly between cancerous and benign lesions at either strength. Healthy muscle did read lower than sarcoma at the stronger field only. The measure, at least in this small sample, cannot yet sort the two tumor kinds.
Catalog record
| CREATOR | Laura Dupont, Bénédicte M A Delattre, Marta Sans Merce, Pierre Alexandre Poletti, Sana Boudabbous, Dania Cioni, Brigitta G Baumert |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 23 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |